Skip to content

Guide · Disputes and Litigation

Product Liability and Recalls in Canada

Product liability in Canada combines federal safety regulation, provincial civil liability and active class action courts. This guide explains CCPSA incident reporting and recall powers, Food and Drugs Act duties for therapeutic products, negligence and failure-to-warn claims, Quebec's stricter Civil Code regime and how to run a recall that also manages litigation risk.

10 min read Updated
ENFR

Key takeaways

  • CCPSA incident information must reach Health Canada within two days of becoming aware of it.
  • Manufacturers or importers must file a written incident report within 10 days unless the Minister sets another period.
  • CCPSA offences carry fines of up to CAD 5 million and two years' imprisonment on indictment.
  • Quebec's Civil Code imposes liability for safety defects on manufacturers, distributors and suppliers.
  • Foreign recalls can be reportable incidents in Canada, so cross-border coordination is essential.

Product liability in Canada explained

Product liability in Canada is built from several layers that apply at the same time. Federal regulatory statutes, chiefly the Canada Consumer Product Safety Act (CCPSA) and the Food and Drugs Act (FDA), impose reporting, recall and safety obligations enforced by Health Canada. Civil liability is governed by provincial law: negligence and contract in the common law provinces, and the Civil Code of Québec and Quebec's Consumer Protection Act in Quebec. On top of both sits class action procedure, which turns individual product complaints into portfolio-level litigation risk. Manufacturers, importers, distributors and retailers can all be exposed, and foreign manufacturers selling into Canada are routinely named as defendants.

Recalled consumer products on a warehouse shelf illustrating product liability and recall duties in Canada
Product safety incidents in Canada can trigger mandatory reporting, recalls and class actions within days.

This page explains the federal regulatory obligations that shape product liability exposure, the civil liability rules in the common law provinces and Quebec, product class actions, recall management and cross-border coordination, and practical steps to reduce risk.

Federal product safety obligations

Canada Consumer Product Safety Act

The CCPSA applies to most consumer products other than those regulated by specific statutes, such as food, drugs, natural health products, medical devices, cosmetics and vehicles. Its core prohibition is in s. 7: a manufacturer or importer may not manufacture, import, advertise or sell a consumer product that is a danger to human health or safety, is subject to a recall order or voluntary recall for that reason, or is subject to a corrective measure that has not been carried out. Section 8 applies a similar prohibition to anyone who advertises or sells a product knowing it is in one of those categories.

The incident reporting obligations in s. 14 drive much of the early response to a safety issue:

  • anyone who manufactures, imports or sells a consumer product for commercial purposes must give Health Canada, and the person from whom they received the product, all information in their control about an incident within two days after becoming aware of it (s. 14(2)); and
  • the manufacturer, or the importer where the manufacturer carries on business outside Canada, must provide a written report within 10 days, or a period the Minister specifies, describing the incident, the product, similar products that could be involved and proposed measures (s. 14(3)).

"Incident" is defined broadly to include occurrences that resulted or may reasonably have been expected to result in death or serious adverse effects on health, defects or characteristics that may reasonably be expected to cause such harm, incorrect or insufficient labelling or instructions, and recalls or measures initiated by foreign entities. Businesses must also keep documents identifying from whom they obtained, or to whom they sold, the product for six years after the end of the year to which they relate (s. 13).

Recalls and orders

If the Minister believes on reasonable grounds that a consumer product is a danger to human health or safety, s. 31 allows an order requiring the manufacturer, importer or seller to recall it, and s. 32 allows orders requiring other corrective measures. Failure to comply with an order is a violation that can attract administrative monetary penalties (s. 49). Contraventions of the Act are offences: on indictment, fines of up to CAD 5 million, imprisonment for up to two years, or both; on summary conviction, fines of up to CAD 250,000 for a first offence and CAD 500,000 for a subsequent offence (s. 41(1)). Directors and officers who directed, authorized, assented to, acquiesced in or participated in an offence are parties to it (s. 42).

Food, drugs and medical devices

For therapeutic products, the FDA, as amended in 2014, allows the Minister to order a recall where a product presents a serious or imminent risk of injury to health (s. 21.3), to require label changes and to order studies (s. 21.32). Prescribed health care institutions must report serious adverse drug reactions and medical device incidents (s. 21.8). Penalties for contraventions relating to therapeutic products mirror the CCPSA: up to CAD 5 million on indictment, and up to CAD 250,000 for a first summary conviction (s. 31.2). Food safety is primarily governed by the Safe Food for Canadians Act and the Canadian Food Inspection Agency.

ObligationSourceTiming or consequence
Report incident information to Health Canada and supplierCCPSA s. 14(2)Within 2 days of becoming aware
Written incident report by manufacturer or importerCCPSA s. 14(3)Within 10 days, or as the Minister specifies
Keep supply-chain documentsCCPSA s. 13Six years after the end of the year concerned
Comply with recall or corrective orderCCPSA ss. 31–32, 49Administrative monetary penalties for non-compliance
Offences under the CCPSACCPSA s. 41Up to CAD 5 million and 2 years on indictment
Therapeutic product recall orderFDA s. 21.3Where serious or imminent risk of injury to health

Civil product liability in the common law provinces

Outside Quebec, product liability claims are usually framed in negligence, with contract and statutory warranty claims where there is privity. Canada has not adopted a general strict liability regime for defective products, so a plaintiff must generally prove that the defendant breached a standard of care. The main theories are:

  • Manufacturing defects: the specific product departed from its intended design.
  • Design defects: the design itself was unreasonably dangerous, often assessed by weighing risks against utility and the availability of a safer alternative design.
  • Failure to warn: manufacturers have a continuing duty to warn consumers of dangers inherent in the use of their products that they know or ought to know about. In Hollis v. Dow Corning Corp., a 1995 decision, the Supreme Court of Canada emphasized that the duty is ongoing and that warnings must be clear and reasonably communicate the nature and extent of the danger, including where they are given through a learned intermediary such as a physician.

Causation and remoteness frequently decide product liability cases. In Mustapha v. Culligan of Canada Ltd., [2008] 2 S.C.R. 114, the Supreme Court held that a supplier was not liable for a customer's psychiatric injury after he saw a dead fly in a bottle of water, because that injury was not a reasonably foreseeable consequence for a person of ordinary fortitude. Contract claims against sellers may also rely on the implied conditions in provincial sale of goods legislation. In Earthco Soil Mixtures Inc. v. Pine Valley Enterprises Inc., 2024 SCC 20, the Supreme Court explained what is needed to contract out of those implied conditions, which is relevant to business-to-business supply contracts.

Product liability in Quebec

Quebec's civil law imposes a stricter regime. Under art. 1468 of the Civil Code of Québec, the manufacturer of a movable thing must make reparation for injury caused to a third person by a safety defect, and the same rule applies to distributors who sell the thing under their own name and to suppliers, including wholesalers, retailers and importers.

A thing has a safety defect where it does not afford the safety a person is normally entitled to expect, including because of design or manufacturing defects or insufficient warnings (art. 1469). The defences in art. 1473 are narrow: the victim knew or could have known of the defect or foreseen the injury, or the defect could not have been known according to the state of knowledge at the time, provided the defendant was not neglectful of its duty to inform once it became aware.

Quebec's Consumer Protection Act adds a direct recourse by the consumer against the merchant or the manufacturer for latent defects, including a lack of instructions needed to protect the user against a risk (s. 53). Combined with Quebec's authorization standard for class actions under art. 575 of the Code of Civil Procedure, this makes Quebec a frequent forum for product liability class actions.

Practical point

The two-day CCPSA reporting clock runs from awareness, not from completion of an internal investigation. Companies selling consumer products in Canada should designate who receives incident information, who decides whether a report is required and who files it, and should rehearse the process before a real incident arrives.

Product class actions and litigation strategy

Product liability class actions in Canada typically follow a recall, a regulatory warning, a foreign recall or a widely reported incident. Claims are often filed in several provinces, including Quebec, Ontario and British Columbia, and may be coordinated with litigation in the United States. Certification in Ontario requires the court to find that a class proceeding is the preferable procedure, including that it is superior to other means and that common issues predominate, while Quebec's authorization threshold is lower.

Key strategic questions in product class actions include whether the alleged defect is common to the class or varies by model, batch or use; whether the claim includes economic loss for non-dangerous defects, which Canadian courts treat with caution; how a recall programme affects damages; and whether experts can prove causation on a class-wide basis. Health-related claims, such as pharmaceutical and medical device litigation, also raise questions about regulatory approvals and the learned intermediary rule. See our pages on class actions and class action settlement approval.

Illustration: a hypothetical European appliance maker learns from a Canadian retailer that several units have overheated, and one caused a minor burn. Within two days it must provide incident information to Health Canada and the retailer; within 10 days it must file a written report covering similar models. If it decides on a voluntary recall, the recall notice, retailer instructions and remedy offered will later be scrutinized in any proposed class action in Quebec and Ontario.

Managing recalls and cross-border product liability

Recalls are both a regulatory obligation and a litigation event. A well-run recall reduces harm and regulatory exposure, but every statement made during it can be quoted in later proceedings. A practical recall plan covers:

  1. Triage: assess the hazard, affected models and lots, and whether the CCPSA or FDA reporting duties have been triggered.
  2. Regulator engagement: coordinate with Health Canada on the recall strategy, notice wording and the remedy, and agree progress reporting.
  3. Supply chain: use the s. 13 traceability records to notify distributors and retailers and stop sales.
  4. Communications: issue bilingual notices; Quebec's Charter of the French Language also governs product information and consumer communications.
  5. Privilege: structure root-cause investigations to protect privileged legal advice where possible.
  6. Insurance and contracts: notify product liability and recall insurers promptly and review indemnities in supply and distribution agreements.

Cross-border coordination is essential. Foreign recalls can themselves be reportable incidents in Canada, and positions taken with the US Consumer Product Safety Commission or European regulators will be compared with those taken with Health Canada. Jurisdiction over foreign manufacturers is assessed under the real and substantial connection test; in Sinclair v. Venezia Turismo, 2025 SCC 27, the Supreme Court declined Ontario jurisdiction over foreign defendants where the only Ontario link was a credit card service. Our insight on jurisdiction over foreign defendants explains the test. Product liability risk also connects to consumer advertising claims under the Competition Act and provincial consumer law, discussed on our consumer protection page.

Allocating product liability risk in contracts

Much product liability exposure is ultimately allocated by contract between the parties in the supply chain. Manufacturers, importers, distributors and retailers in Canada should check that their agreements deal expressly with the following points, since the statutory duties described above apply to several of them at once:

  • Regulatory cooperation: who reports incidents under the CCPSA or FDA, how incident information is shared within the two-day window and who controls communications with Health Canada.
  • Recall costs: who decides whether to recall, who bears logistics, refunds, replacement products and retailer costs, and whether recall insurance responds.
  • Indemnities: the scope of indemnities for third-party claims, including class actions, defence costs and settlements, and any caps or exclusions.
  • Warranties and implied conditions: whether statutory implied conditions of fitness and merchantable quality are excluded or limited, and whether the exclusion is clear enough to be effective.
  • Quality and traceability: batch tracking, record keeping to match the six-year CCPSA retention period, and audit rights over suppliers.
  • Governing law and forum: particularly for foreign suppliers, where enforcement of an indemnity may depend on a foreign court or arbitral tribunal.

Consumer-facing terms raise separate issues. Limitations of liability that would be acceptable between businesses are often unenforceable against consumers, particularly in Quebec, where the Consumer Protection Act restricts exclusions of the legal warranty. Product labelling, packaging and instructions must also comply with federal bilingual labelling rules and, in Quebec, the Charter of the French Language, which matters for failure-to-warn arguments as well as regulatory compliance. Reviewing these documents together, rather than separately by the legal, regulatory and marketing teams, avoids inconsistencies that plaintiffs can later exploit.

How TRW & Co helps

We advise manufacturers, importers, distributors and retailers on product liability in Canada: building CCPSA and FDA incident reporting procedures, managing recalls with Health Canada, assessing exposure under negligence law and the Civil Code of Québec, defending and coordinating product class actions across provinces and with foreign proceedings, and reviewing supply, distribution and indemnity terms. For court appearances and Quebec-specific advice we work with Canadian-licensed counsel. This page is general information, not legal advice. To discuss a product safety incident or claim, please contact us.

Frequently asked questions

When must a company report a product incident to Health Canada?

Under s. 14(2) of the Canada Consumer Product Safety Act, a person who manufactures, imports or sells a consumer product for commercial purposes must provide all information in its control about an incident within two days after becoming aware of it. The manufacturer, or the importer if the manufacturer is outside Canada, must then file a written report within 10 days unless the Minister specifies another period.

Is product liability strict in Canada?

Not in the common law provinces, where claims generally require proof of negligence, such as a manufacturing defect, unsafe design or inadequate warning, or a breach of contract or statutory warranty. Quebec is different: the Civil Code makes manufacturers, distributors and suppliers liable for injury caused by a safety defect, subject to narrow defences in art. 1473.

Can Health Canada force a recall?

Yes. Under s. 31 of the CCPSA, the Minister may order a manufacturer, importer or seller to recall a consumer product that the Minister believes on reasonable grounds is a danger to human health or safety. For therapeutic products, s. 21.3 of the Food and Drugs Act allows recall orders where there is a serious or imminent risk of injury to health.

Are foreign manufacturers exposed to Canadian product claims?

Often, yes. Canadian courts take jurisdiction where there is a real and substantial connection to the province, which product sales and injuries in Canada frequently establish. Foreign recalls may also be reportable incidents under the CCPSA, so foreign manufacturers should align their Canadian regulatory filings and public statements with those made elsewhere.

Do directors face personal exposure under the CCPSA?

Yes. Under s. 42 of the CCPSA, directors, officers, agents and mandataries of a corporation who directed, authorized, assented to, acquiesced in or participated in an offence are parties to the offence and liable to the punishment provided, whether or not the corporation is prosecuted. A due diligence defence is available under the Act.

Sources

  1. Canada Consumer Product Safety Act (S.C. 2010, c. 21)
  2. Food and Drugs Act (R.S.C. 1985, c. F-27)
  3. Civil Code of Québec, arts. 1468–1473 (LégisQuébec)
  4. Consumer Protection Act, CQLR c. P-40.1 (LégisQuébec)
  5. Hollis v. Dow Corning Corp. (Supreme Court of Canada)

General information only, not legal advice. References to statutes, courts and authorities describe published law and practice at the date shown.